IDEXX Laboratories Revenue 2010-2025 | IDXX
IDEXX Laboratories annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- IDEXX Laboratories revenue for the quarter ending June 30, 2025 was $1.109B, a 10.55% increase year-over-year.
- IDEXX Laboratories revenue for the twelve months ending June 30, 2025 was $4.038B, a 6.68% increase year-over-year.
- IDEXX Laboratories annual revenue for 2024 was $3.898B, a 6.46% increase from 2023.
- IDEXX Laboratories annual revenue for 2023 was $3.661B, a 8.72% increase from 2022.
- IDEXX Laboratories annual revenue for 2022 was $3.367B, a 4.73% increase from 2021.
| IDEXX Laboratories Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $3,898 |
| 2023 | $3,661 |
| 2022 | $3,367 |
| 2021 | $3,215 |
| 2020 | $2,707 |
| 2019 | $2,407 |
| 2018 | $2,213 |
| 2017 | $1,969 |
| 2016 | $1,775 |
| 2015 | $1,602 |
| 2014 | $1,486 |
| 2013 | $1,377 |
| 2012 | $1,293 |
| 2011 | $1,219 |
| 2010 | $1,103 |
| 2009 | $1,032 |
| IDEXX Laboratories Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,109 |
| 2025-03-31 | $998 |
| 2024-12-31 | $954 |
| 2024-09-30 | $976 |
| 2024-06-30 | $1,004 |
| 2024-03-31 | $964 |
| 2023-12-31 | $902 |
| 2023-09-30 | $916 |
| 2023-06-30 | $944 |
| 2023-03-31 | $900 |
| 2022-12-31 | $829 |
| 2022-09-30 | $842 |
| 2022-06-30 | $861 |
| 2022-03-31 | $837 |
| 2021-12-31 | $801 |
| 2021-09-30 | $810 |
| 2021-06-30 | $826 |
| 2021-03-31 | $778 |
| 2020-12-31 | $721 |
| 2020-09-30 | $722 |
| 2020-06-30 | $638 |
| 2020-03-31 | $626 |
| 2019-12-31 | $605 |
| 2019-09-30 | $605 |
| 2019-06-30 | $620 |
| 2019-03-31 | $576 |
| 2018-12-31 | $549 |
| 2018-09-30 | $545 |
| 2018-06-30 | $581 |
| 2018-03-31 | $538 |
| 2017-12-31 | $506 |
| 2017-09-30 | $492 |
| 2017-06-30 | $509 |
| 2017-03-31 | $462 |
| 2016-12-31 | $443 |
| 2016-09-30 | $448 |
| 2016-06-30 | $467 |
| 2016-03-31 | $418 |
| 2015-12-31 | $400 |
| 2015-09-30 | $406 |
| 2015-06-30 | $413 |
| 2015-03-31 | $382 |
| 2014-12-31 | $352 |
| 2014-09-30 | $384 |
| 2014-06-30 | $390 |
| 2014-03-31 | $360 |
| 2013-12-31 | $354 |
| 2013-09-30 | $338 |
| 2013-06-30 | $353 |
| 2013-03-31 | $332 |
| 2012-12-31 | $320 |
| 2012-09-30 | $315 |
| 2012-06-30 | $336 |
| 2012-03-31 | $323 |
| 2011-12-31 | $307 |
| 2011-09-30 | $301 |
| 2011-06-30 | $318 |
| 2011-03-31 | $293 |
| 2010-12-31 | $284 |
| 2010-09-30 | $270 |
| 2010-06-30 | $281 |
| 2010-03-31 | $269 |
| 2009-12-31 | $270 |
| 2009-09-30 | $259 |
| 2009-06-30 | $266 |
| 2009-03-31 | $236 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $51.647B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $188.802B | 22.84 |
| Intuitive Surgical (ISRG) | United States | $170.692B | 70.75 |
| Edwards Lifesciences (EW) | United States | $48.042B | 31.84 |
| Alcon (ALC) | Switzerland | $40.456B | 27.16 |
| IQVIA Holdings (IQV) | United States | $32.496B | 18.36 |
| DexCom (DXCM) | United States | $32.259B | 48.39 |
| Mettler-Toledo (MTD) | United States | $27.221B | 32.31 |
| STERIS (STE) | Ireland | $24.807B | 26.40 |
| Waters (WAT) | United States | $17.988B | 24.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.319B | 0.00 |
| Hologic (HOLX) | United States | $15.182B | 16.45 |
| Penumbra (PEN) | United States | $10.325B | 75.42 |
| Globus Medical (GMED) | United States | $8.444B | 19.48 |
| Sysmex ADR (SSMXY) | Japan | $8.410B | 26.72 |
| Masimo (MASI) | United States | $8.074B | 27.17 |
| Teleflex (TFX) | United States | $5.719B | 9.23 |
| Glaukos (GKOS) | United States | $5.400B | 0.00 |
| TransMedics (TMDX) | United States | $4.086B | 62.10 |
| Integer Holdings (ITGR) | United States | $3.874B | 19.33 |
| LivaNova (LIVN) | United Kingdom | $3.052B | 17.47 |
| Veracyte (VCYT) | United States | $2.439B | 33.70 |
| Alphatec Holdings (ATEC) | United States | $2.388B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.294B | 0.00 |
| Artivion (AORT) | United States | $2.115B | 106.74 |
| Elekta AB (EKTAY) | Sweden | $1.924B | 18.00 |
| Nihon Kohden (NHNKY) | Japan | $1.914B | 22.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.158B | 6.63 |
| Pulse Biosciences (PLSE) | United States | $1.147B | 0.00 |
| OPKO Health (OPK) | United States | $1.119B | 0.00 |
| IRadimed (IRMD) | United States | $0.924B | 44.85 |
| Tandem Diabetes Care (TNDM) | United States | $0.806B | 0.00 |
| AxoGen (AXGN) | United States | $0.748B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.741B | 0.00 |
| SiBone (SIBN) | United States | $0.707B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.543B | 9.60 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.465B | 3.74 |
| Pacific Biosciences Of California (PACB) | United States | $0.415B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.401B | 10.20 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.67 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| RxSight (RXST) | United States | $0.380B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.304B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.295B | 20.35 |
| Spectral Diagnostics (EDTXF) | Canada | $0.289B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.268B | 0.00 |
| 908 Devices (MASS) | United States | $0.231B | 0.00 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.221B | 0.00 |
| Inogen (INGN) | United States | $0.210B | 0.00 |
| CVRx (CVRX) | United States | $0.204B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.175B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.163B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.102B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| InspireMD (NSPR) | United States | $0.099B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.082B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.55 |